108 common laboratory cell lines
108 common laboratory cell lines
No. | Cell line | Species | Cell type | Growth pattern | Commonly used media | Commonly used serum |
1 | HEK293 | Human | Fetal kidney epithelial-like cells | Adherent, epithelial-like | 10% FBS | |
2 | HepG2.2.15 | Human | Hepatocellular carcinoma cells | Adherent, epithelial-like | 15% FBS | |
3 | 12TAg | Mouse | Pluripotent embryonic stem cell-like | Embryonic-type colonies | 10% FBS | |
4 | 293/CHE-Fc | Human | Kidney epithelial-like cells | Adherent, epithelial-like | 10% FBS | |
5 | 3T3-L1 | Mouse | Embryonic fibroblasts / preadipocytes | Adherent, fibroblast-like | 10% FBS | |
6 | 3T6 | Mouse | Embryonic fibroblasts | Adherent, fibroblast-like | 10% FBS | |
7 | A431 | Human | Epidermoid squamous cell carcinoma | Adherent, epithelial-like | 10% FBS | |
8 | A549 | Human | Lung carcinoma epithelial cells | Adherent, epithelial-like | F-12 (Kaighn’s) | 10% FBS |
9 | A9 | Mouse | Connective tissue fibroblasts | Adherent, fibroblast-like | 10% FBS | |
10 | AR42J | Rat | Pancreatic tumor epithelial-like cells | Adherent, epithelial-like | 20% FBS | |
11 | AtT-20 | Mouse | Pituitary tumor cells | Adherent, epithelial-like | F-10 | 15% HS + 2.5% FBS |
12 | B95-8 | Marmoset | EBV-infected lymphoid-like cells | Suspension, lymphoid-like | 10% FBS | |
13 | BALB/3T3 | Mouse | Embryonic fibroblasts | Adherent, fibroblast-like | 10% FBS | |
14 | Bel-7402 | Human | Hepatocellular carcinoma cells | Adherent, epithelial-like | 15% FBS | |
15 | BeWo | Human | Choriocarcinoma epithelial cells | Adherent, epithelial-like | 15% FBS | |
16 | BHK-21 | Hamster | Kidney fibroblast-like cells | Adherent, fibroblast-like | 10% FBS | |
17 | HBL-100 | Human | Mammary epithelial cells | Adherent, epithelial-like | 10% FBS | |
18 | BRL-3A | Rat | Liver epithelial cells | Adherent, epithelial-like | 10% FBS | |
19 | BT | Bovine | Turbinate bone–derived fibroblasts | Adherent, fibroblast-like | 10% FBS | |
20 | Caco-2 | Human | Colonic adenocarcinoma epithelial cells | Adherent, epithelial-like | 10% FBS | |
21 | Chang | Human | Liver epithelial cells | Adherent, epithelial-like | 10% FCS | |
22 | CHO-K1 | Hamster | Ovarian epithelial cells | Adherent, epithelial-like | 10% FBS | |
23 | CL2 | Mouse | B cells (hybridoma-like) | Suspension, lymphocyte-like | 10% FBS | |
24 | CL3 | Mouse | B cells (hybridoma-like) | Suspension, lymphocyte-like | 10% FBS | |
25 | Clone 9 | Rat | Liver epithelial cells | Adherent, epithelial-like | 10% FBS | |
26 | Clone M-3 | Mouse | Melanoma cells | Adherent, epithelial-like | 15% HS + 2.5% FBS | |
27 | COS-1 | African green monkey | Kidney fibroblast-like cells | Adherent, fibroblast-like | 10% FBS | |
28 | COS-3 | Monkey | Kidney fibroblast-like cells | Adherent, fibroblast-like | 10% FBS | |
29 | COS-7 | African green monkey | Kidney fibroblast-like cells | Adherent, fibroblast-like | 10% FBS | |
30 | CRFK | Cat | Kidney epithelial cells | Adherent, epithelial-like | 10% FBS | |
31 | CV-1 | African green monkey | Kidney fibroblast-like cells | Adherent, fibroblast-like | 10% FBS | |
32 | D-17 | Dog | Osteosarcoma cells | Adherent, epithelial-like | 10% FBS | |
33 | DAN | Dog | Osteosarcoma cells | Adherent, epithelial-like | 8% FBS | |
34 | Daudi | Human | Burkitt lymphoma B cells | Suspension, lymphoid-like | 10% FBS | |
35 | DLD-1 | Human | Colorectal adenocarcinoma cells | Adherent, epithelial-like | 10% FBS | |
36 | DSDh | Dog | Osteosarcoma cells | Adherent, epithelial-like | 8% FBS | |
37 | DSN | Dog | Osteosarcoma cells | Adherent, epithelial-like | 10% FBS | |
38 | Du145 | Human | Prostate carcinoma cells | Adherent, epithelial-like | 10% FBS | |
39 | EB-3 | Human | Burkitt lymphoma B cells | Suspension, lymphoid-like | 10% FBS | |
40 | ES-D3 | Mouse | Pluripotent embryonic stem cells | Embryonic-type colonies | 15% FBS | |
41 | F9 | Mouse | Testicular teratocarcinoma embryonal-like cells | Embryonic to endoderm-like | 15% FBS | |
42 | GH1 | Rat | Pituitary tumor cells | Adherent, epithelial-like | 15% HS + 2.5% FBS | |
43 | GH3 | Rat | Pituitary tumor cells | Adherent, epithelial-like | 15% HS + 2.5% FBS | |
44 | H9 | Human | T-cell lymphoma cells | Suspension, lymphoblast-like | 10% FBS | |
45 | H9/HTLV-IIIB | Human | T-cell lymphoma (HIV/HTLV-infected) | Suspension, lymphoblast-like | 10% FBS | |
46 | HaK | Hamster | Kidney epithelial cells | Adherent, epithelial-like | 10% FCS | |
47 | HCT-15 | Human | Colorectal adenocarcinoma cells | Adherent, epithelial-like | 10% FBS | |
48 | HeLa | Human | Cervical carcinoma epithelial cells | Adherent, epithelial-like | 10% FBS | |
49 | HeLa S3 | Human | Cervical carcinoma subclone | Adherent, epithelial-like | 10% FBS | |
50 | Hep-2 | Human | Laryngeal carcinoma epithelial cells (HeLa-like) | Adherent, epithelial-like | 10% FBS | |
51 | Hep3B | Human | Hepatocellular carcinoma cells | Adherent, epithelial-like | 10% FBS | |
52 | HepG2 | Human | Hepatocellular carcinoma cells | Adherent, epithelial-like | 10% FBS | |
53 | HK-2 | Human | Renal cortical epithelial cells | Adherent, epithelial-like | Keratinocyte SFM | Serum-free (with rhEGF etc.) |
54 | HL-60 | Human | Acute promyelocytic leukemia cells | Suspension, granulocyte-like | 20% FBS | |
55 | HP1 (HT1080 poly) | Human | Fibrosarcoma cells | Adherent, epithelial-like | 10% FBS | |
56 | HT-1080 | Human | Fibrosarcoma cells | Adherent, epithelial-like | 10% FBS | |
57 | HT-29 | Human | Colon adenocarcinoma cells | Adherent, epithelial-like | 5% FBS | |
58 | HTC | Rat | Liver epithelial cells | Adherent, epithelial-like | 10% FBS | |
59 | HuT 78 | Human | T-cell lymphoma cells | Suspension, lymphoblast-like | 20% FBS | |
60 | HUVEC | Human | Umbilical vein endothelial cells | Adherent, epithelial-like | 10% FBS + heparin 100 μg/mL | |
61 | HX (HT108 xeno) | Human | Fibrosarcoma (HT1080 xenograft–derived) | Adherent, epithelial-like | 10% FBS | |
62 | I-10 | Mouse | Testicular tumor cells | Adherent, epithelial-like | F-10 | 15% HS + 2.5% FBS |
63 | IEC-6 | Rat | Normal small intestinal epithelial-like cells | Adherent, epithelial-like | 5% FBS + insulin 0.1 μg/mL | |
64 | IM-9 | Human | Bone marrow B cells from multiple myeloma patient | Suspension, lymphoid-like | 10% FBS | |
65 | IMR-90 | Human | Lung fibroblasts | Adherent, fibroblast-like | 10% FBS | |
66 | JAA-F11 | Mouse | B-cell hybridoma | Suspension, lymphoid-like | 10% FBS | |
67 | JEG-3 | Human | Choriocarcinoma epithelial cells | Adherent, epithelial-like | 10% FBS | |
68 | Jensen | Rat | Sarcoma fibroblast-like cells | Adherent, fibroblast-like | 5% FBS | |
69 | Jurkat | Human | Acute T-cell leukemia cells | Suspension, lymphoid-like | 10% FBS | |
70 | K-562 | Human | Chronic myelogenous leukemia cells | Suspension, lymphoblast-like | 10% FBS | |
71 | KB | Human | Oral carcinoma epithelial cells | Adherent, epithelial-like | 10% FBS | |
72 | KG-1 | Human | Erythroleukemia bone marrow cells | Suspension, myeloblast-like | 20% FBS | |
73 | KG-1a | Human | KG-1 subline bone marrow cells | Suspension, myeloblast-like | 20% FBS | |
74 | L2 | Rat | Lung epithelial cells | Adherent, epithelial-like | 10% FBS | |
75 | L6 | Rat | Skeletal muscle myoblasts | Adherent, myoblast-like | 10% FBS | |
76 | LLC-WRC 256 | Rat | Carcinoma cells (Walker 256–derived) | Adherent, epithelial-like | 5% HS | |
77 | LnCap | Human | Prostate carcinoma cells | Adherent, epithelial-like | 10% FBS | |
78 | LO2 | Human | Normal liver epithelial cells | Adherent, epithelial-like | 15% FBS | |
79 | M. dunni (Clone IIIBC) | Mouse | Skin fibroblasts | Adherent, fibroblast-like | 10% FBS | |
80 | MARC S5 | Mouse | B-cell hybridoma | Suspension, lymphoid-like | 20% heat-inactivated FBS | |
81 | MCF-7 | Human | Breast carcinoma epithelial cells | Adherent, epithelial-like | 10% FBS + insulin 10 μg/mL | |
82 | MHCC97 | Human | Hepatocellular carcinoma cells | Adherent, epithelial-like | 15% FBS | |
83 | MOLT-4 | Human | Acute T-lymphoblastic leukemia cells | Suspension, lymphoid-like | 10% FBS | |
84 | NIH3T3 | Mouse | Embryonic fibroblasts | Adherent, fibroblast-like | 15% FBS | |
85 | NK-92 | Human | NK-cell lymphoma | Suspension, lymphoblast-like | 12.5% HS + 12.5% FBS (+ IL-2) | |
86 | NK-92MI | Human | NK-92 autocrine IL-2 variant | Suspension, lymphoblast-like | 12.5% HS + 12.5% FBS | |
87 | PANC-1 | Human | Pancreatic carcinoma epithelial cells | Adherent, epithelial-like | 10% FBS | |
88 | PC12 | Rat | Adrenal pheochromocytoma cells | Loosely adherent, easily aggregated | 15% HS + 2.5% FBS | |
89 | PC3 | Human | Prostatic adenocarcinoma (bone metastasis) | Adherent, epithelial-like | 10% FBS | |
90 | Raji | Human | Burkitt lymphoma B cells | Suspension, lymphoid-like | 10% FBS | |
91 | Rat2 | Rat | Embryonic fibroblasts (Rat2 clone) | Adherent, fibroblast-like | 5% FBS + BrdU 30 μg/mL | |
92 | RS4;11 | Human | Acute lymphoblastic leukemia cells | Suspension, lymphoblast-like | 10% FBS | |
93 | Saos-2 | Human | Osteosarcoma epithelial-like cells | Adherent, epithelial-like | 15% FBS | |
94 | SMMC7721 | Human | Hepatocellular carcinoma cells | Adherent, epithelial-like | 15% FBS | |
95 | SP2/0 | Mouse | Myeloma hybridoma parent line | Suspension, hybridoma-like | 7.5% FBS | |
96 | SW480 | Human | Colon carcinoma epithelial cells | Adherent, epithelial-like | L-15 | 10% FBS |
97 | SW620 | Human | Colon carcinoma epithelial cells | Adherent, epithelial-like | L-15 | 10% FBS + 2 mM L-glutamine |
98 | THP-1 | Human | Acute monocytic leukemia cells | Suspension, monocyte-like | 10% FBS | |
99 | U937 | Human | Histiocytic lymphoma / monocytic leukemia cells | Suspension, monocyte-like | 10% FBS | |
100 | Vero | African green monkey | Kidney epithelial cells | Adherent, epithelial-like | 10% FBS | |
101 | Vero-E6 | African green monkey | Kidney epithelial cells | Adherent, epithelial-like | 10% FBS | |
102 | WEHI-3 | Mouse | Myelomonocytic leukemia cells | Suspension, macrophage-like | 10% FBS | |
103 | WI-38 | Human | Embryonic lung fibroblast / epithelial-like cells | Adherent, epithelial-like | 10% FBS | |
104 | WISH | Human | Amniotic epithelial cells | Adherent, epithelial-like | 10% FBS | |
105 | WS1 | Human | Embryonic skin epithelial cells | Adherent, epithelial-like | 10% FBS | |
106 | WSS-1 (WS-1) | Human | Kidney epithelial cells | Adherent, epithelial-like | 10% FBS | |
107 | XC | Rat | Sarcoma epithelial-like cells | Adherent, epithelial-like | 10% FBS | |
108 | Y-1 | Mouse | Adrenal tumor epithelial cells | Adherent, epithelial-like | F-10 | 15% HS + 2.5% FBS |
Aladdin: https://www.aladdinsci.com/
